Clinical trial
Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism…
NCT00497484 · University of Milan, Other · Unknown status
Key facts
| NCT number | NCT00497484 |
|---|---|
| Title | Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia) |
| Official title | Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia) |
| Lead sponsor | University of Milan, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Pseudohypoparathyroidism, Growth Hormone Deficiency, Dwarfism |
| Intervention type | Drug |
| Interventions | recombinant human somatotropin |
| First posted | Jul 6, 2007 |
| Last update posted | Jul 6, 2007 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: